Skip to the page

Data / Form D filings / Metanoia Bio Inc

Metanoia Bio Inc: Form D filing

Metanoia Bio Inc, a biotechnology company in Lewes, DE, filed a Form D with the SEC in 2026. The latest, on March 18, 2026, reports $900,000 sold of a $5 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
16192 COASTAL HIGHWAY ,, Lewes, DE, 19958
Phone
1-855-337-4905
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2121615

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 18, 2026New notice$5,000,000$900,000$4,100,0005Mar 2, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brent CohenExecutive Officer, Director, PromoterCoFounder
Abraham Van WykExecutive Officer, Director, PromoterCofounder
Oppel GreeffDirector, PromoterCofounder
Slavica TudzarovaPromoterScientific Cofounder
Hilton MendelsohnPromoterCofounder

Other biotechnology companies in Delaware that filed recently

Every Form D from the week of Mar 16, 2026 · All recent filings in Delaware · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Metanoia Bio Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.